Human SOX10 mutations lead to various diseases including Waardenburg syndrome, Hirschsprung disease, peripheral demyelinating neuropathy, central leukodystrophy, Kallmann syndrome and various combinations thereof. It has been postulated that PCWH as a combination of Waardenburg and Hirschsprung disease, peripheral neuropathy and central leukodystrophy is caused by heterozygous SOX10 mutations that result in the presence of a dominantly acting mutant SOX10 protein in the patient. One such protein with postulated dominant action is SOX10 Q377X. In this study, we generated a mouse model, in which the corresponding mutation was introduced into the Sox10 locus in such a way that Sox10 Q377X is constitutively expressed. Heterozygous mice carrying this mutation exhibited pigmentation and enteric nervous system defects similar to mice in which one Sox10 allele was deleted. However, despite presence of the mutant protein in Schwann cells and oligodendrocytes throughout development and in the adult, we found no phenotypic evidence for neurological defects in peripheral or central nervous systems. In the nervous system, the mutant Sox10 protein did not act in a dominant fashion but rather behaved like a hypomorph with very limited residual function. Our results question a strict genotypephenotype correlation for SOX10 mutations and argue for the influence of additional factors including genetic background.
Introduction
The transcription factor Sox10 is an important regulator in neural crest and central nervous system (CNS) in all vertebrates so that mutation or deletion of the Sox10 gene lead to severe developmental disturbances (1) . In humans, SOX10 mutations are usually sporadic and heterozygous. They may cause several diseases, including Waardenburg syndrome as a melanocyte defect, Hirschsprung disease as a defect of the enteric nervous system, peripheral demyelinating neuropathy as a Schwann cell defect, central dysmyelinating leukodystrophy as an oligodendrocyte defect, and Kallmann syndrome as a defect in olfactory ensheathing cells, that prevents migration of neurons from the olfactory placode into the CNS and thereby interferes with production of gonadotropin releasing hormone from these neurons in the hypothalamus (2) (3) (4) (5) (6) . Frequently patients suffer from a combination of these defects. The most common syndrome observed is Waardenburg-Hirschsprung disease; the most dramatic is PCWH where Peripheral demyelinating neuropathy and Central dysmyelinating leukodystrophy are combined with Waardenburg and Hirschsprung diseases. Corresponding Online Mendelian Inheritance in Man (OMIM) numbers are #609136, #611584 and #613266.
Depending on the severity of myelin defects in peripheral nervous system (PNS) and CNS, PCWH patients exhibit variable symptoms that often include delayed motor and cognitive development, cerebral palsy, ataxia, spasticity, congenital nystagmus, hyporeflexia, distal sensory impairments and distal muscle wasting.
Determinants of the exact disease phenotype are still not completely clear but include the genetic background. At least in the decision between isolated Waardenburg or WaardenburgHirschsprung disease the same mutation can give rise to both (7) . Additionally, the exact type of SOX10 mutation appears to play a role (2, 8) .
Numerous disease-causing missense, nonsense, frameshift and deletion mutations have been identified for SOX10 (7) . A comparison of the SOX10 nonsense and frameshift mutations has led to the observation that mutations in the last exon are frequently associated with PCWH, whereas their occurrence in the preceding exons usually correlates with Waardenburg, Hirschsprung or Waardenburg-Hirschsprung diseases (2) . In vitro experimental evidence argued that differential susceptibility of mutant transcripts to nonsense-mediated decay (NMD) may lie at the bottom of this phenomenon, as nonsense and frameshift mutations often escape NMD when localized in the last exon. The altered proteins generated from these transcripts may then exert a dominant function and cause PCWH. In all other cases, proteins may not be produced, resulting in haploinsufficiency and a milder disease phenotype such as Waardenburg, Hirschsprung or Waardenburg-Hirschsprung syndrome that is also observed following heterozygous SOX10 deletion. Although differential NMD susceptibility of mutant transcripts represents an attractive hypothesis, there is little in vivo evidence so far.
In principle, such evidence may be obtained in model organisms as Sox10 function is highly conserved in vertebrates with homozygous loss or inactivation leading to developmental defects in oligodendrocytes of the CNS and several neural crest lineages including melanocytes, cells of the enteric nervous system and peripheral glia such as Schwann cells and olfactory ensheathing cells (9) (10) (11) (12) (13) (14) .
Recently, Ito et al. (15) generated a mouse model in which a PCWH-associated mutant SOX10 protein is produced from a BAC transgene. The underlying SOX10 mutation (SOX10 c.1400del12) deletes 12 base pairs in the last exon at the end of the open reading frame including the stop codon and thereby extends translation into the 3 0 UTR so that 82 amino acids are added to the carboxyterminus (16) . With increasing number of transgene copies, animals exhibit a delay in the differentiation of Schwann cells and oligodendrocytes, and a hypomyelinating phenotype that is more prominent in the CNS than in the peripheral nerve (15) . This study supports a causal link between the presence of the mutant SOX10 protein and the PCWH phenotype. However, the mutant SOX10 protein is special in that it carries additional amino acids, whereas most other mutations in the last exon lead to truncated proteins without the carboxyterminal transactivation domain. Additionally, the mutant SOX10 is expressed on top of normal levels of wild-type Sox10 in transgenic animals. This contrasts with the situation in patients where the mutant allele replaces one of the normal alleles. Therefore, we initiated a complementary study on a mutation that leads to a truncated SOX10. To test whether expression of a truncated Sox10 would result in a PCWH-like disease phenotype in mice, we have generated a mouse model in which the Q377X nonsense mutant is expressed from the Sox10 locus. This mutant has been associated with neurological phenotypes in the affected human patients including delayed development, cerebral palsy, ataxia and congenital nystagmus (4) . The Q377X mutant lacks the complete carboxyterminal transactivation domain and may thus be expected to interfere with the function of wild-type Sox10 and to exert a dominant effect.
Results

Generation of mice expressing the Sox10 Q377X mutant
Using homologous recombination in mouse ES cells, we have previously generated several alleles in which we have replaced the protein-coding exons 3-5 from the Sox10 gene by a single exon that contains the continuous open reading frame for wildtype or mutant Sox10 proteins (17, 18) . This exon is faithfully spliced to the preceding two exons. The resulting mRNA is translated in the expected spatiotemporal pattern and in wildtype levels (17, 18) .
To generate the mutant Sox10 Q377X allele (Sox10
377X
), we employed a similar strategy (Fig. 1A-D) . We inserted the complete open reading frame for the Sox10 Q377X variant into exon 3 in such a way that the translation start for the mutant was at the wild-type position, and deleted all wild-type sequences behind the translation start (Fig. 1A) . Additionally, we inserted a floxed neomycin cassette with three polyadenylation sites into intron 2. This stopflox cassette causes premature termination of transcription and thus prevents protein production from the mutant Sox10 locus.
Using homologous recombination, we generated ES cell clones that had one mutant Sox10 allele (Sox10 Sfl ) with stopflox cassette (Fig. 1B) . Sox10 þ/Sfl mice were produced from one correctly recombined ES cell clone (Fig. 1C) . Immunohistochemistry on Sox10 Sfl/Sfl embryos at E12.5 confirmed that no Sox10 protein is produced from this allele (Fig. 1E ). Cre-mediated removal of the stopflox cassette was performed to convert the Sox10 Sfl allele into the Sox10 377X allele (Fig. 1A and D mice were not viable. They died immediately after birth so that analysis of homozygous animals had to be restricted to pre-and perinatal stages.
Effects of Sox10 Q377X on peripheral nerves and PNS myelin
To study the consequences of Sox10 Q377X expression on peripheral nerves, we first analyzed spinal nerves of Sox10
embryos at E18.5 and compared them with those of agematched wild-type and Sox10 lacZ/lacZ embryos ( Fig. 2A-I ). At this time, wild-type spinal nerves contain a high number of Sox10-positive Schwann cells ( Fig. 2A) . Most of them have already entered the promyelinating stage and are Oct6-positive (Fig. 2D) . Some have even progressed to the myelinating stage as evident by their Krox20 expression (Fig. 2G) are also thinner in CNS-proximal regions (2.7 6 0.5-fold; n ¼ 3) and sometimes appear defasciculated in more distal regions ( Fig. 2 and data not shown). These PNS defects likely contribute to the perinatal death of Sox10 377X/377X mice.
Postnatal analysis had to be restricted to Sox10 þ/377X mice.
On a gross morphological level, Sox10 þ/377 mice phenotypically resembled Sox10 þ/lacZ mice on a comparable genetic background. When backcrossed on a C3H background, a white belly spot was fully penetrant in Sox10 þ/377X mice and Sox10 þ/lacZ mice from second generation onwards, whereas < 5% of Sox10
and Sox10 þ/lacZ mice succumbed to a megacolon around the time of weaning (19) . These phenotypic alterations correspond to Waardenburg and Hirschsprung symptoms observed in human patients heterozygous for the mutation.
To check for additional phenotypic changes that are indicative of peripheral neuropathies, we investigated the PNS in Sox10 þ/377X mice. Most of the analyses were performed on the sciatic nerve as a well-studied peripheral nerve. First, we compared Sox10 expression levels in wild-type and Sox10 þ/377X nerve tissue. Quantitative rtPCR studies showed that total amounts of Sox10 transcripts in the sciatic nerve were nearly identical in both genotypes at P8, whereas the amount of wild-type transcripts was halved ( Fig. 3A and B ). This argues that wild-type and mutant allele are expressed at similar levels in the nerve. Amounts of Sox8 transcripts were also comparable between genotypes and Sox9 transcripts remained undetectable in Sox10 þ/377X nerve tissue, indicating that the Sox10 mutation did not cause a compensatory upregulation of paralogous Sox genes ( Fig. 3C and D) . Phenotypic analysis of the sciatic nerve was performed at P3 and P7 as times when myelination is ongoing, P21 as an age where myelination is complete, and P60 as a stage of myelin maintenance. At all stages sciatic nerves of Sox10 þ/377X mice were compared with those of wild-type mice and Sox10 We failed to detect substantial numbers of Sox2-positive cells in the sciatic nerve of any genotype (Fig. 3U ). In the wild-type, expression of Sox2 as a marker for the immature Schwann cell stage is dramatically reduced before birth, and its postnatal presence is usually associated with pathological alterations or regenerative events. The absence of Sox2 in sciatic nerves of Sox10 þ/377X and Sox10 þ/lacZ mice at P3 argues against major disturbances of Schwann cell development at this time. This conclusion is also supported by the number of Iba1-positive macrophages in the nerves of Sox10 þ/377X and Sox10 þ/lacZ mice, which is low and comparable to the wildtype (Fig. 3V) . Similar studies were also carried out at P7, P21 and P60 ( Fig. 4A-E) . None of the analyzed Schwann cell markers pointed to alterations in number (Sox10, Fig. 4A ) or differentiation status (Krox20 versus Sox2, Fig. 4B and C) . Expression of myelin genes such as Mbp and Mpz was comparable among the three analyzed genotypes at all time points (Fig. 4D and data not shown) . Inflammatory changes were not detected and numbers of Iba1-positive macrophages were not higher in sciatic nerves of Sox10 þ/377X and Sox10 þ/ lacZ mice than wild-type mice (Fig. 4E and data not shown).
Ultrastructural analysis of sciatic nerves at P60 failed to reveal substantial differences among genotypes (Fig. 5A) . The distribution of large and small caliber axons was comparable for sciatic nerves of Sox10
þ/lacZ and wild-type mice (Fig. 5B) . G ratios pointed to a similar thickness of the myelin sheaths ( Fig. 5C and D transcripts in the sciatic nerve of wild-type (þ/þ) and Sox10 þ/377X (þ/377X) mice at P8. After normalization to Rpl8, total and wild-type Sox10 as well as Sox8 transcript levels in wild-type mice were arbitrarily set to 1 and levels in Sox10
mice were expressed relative to it þ SEM (A-C, n ¼ 3). Sox9 transcripts were not (Figs 6N and 7E) . Compared with the wildtype, the number of Mbp and Plp1-expressing oligodendrocytes was strongly reduced in Sox10 377X/377X mice ( Fig. 6Q and T) .
Despite the strong decrease, numbers were, however, substantially higher than in Sox10 lacZ/lacZ embryos ( Fig. 7F and G) . This was surprising as it points to residual function in the Sox10 Q377X mutant protein.
To assess the impact of the Sox10 Q377X mutant on postnatal oligodendroglial development and homeostasis, we again had to turn to heterozygous mice. We first determined Sox10 expression levels in the spinal cord of Sox10 þ/377X relative to wild-type mice. Quantitative rtPCR revealed that amounts of all Sox10 transcripts were comparable between genotypes, whereas amounts of wild-type Sox10 transcripts were only half as high in Sox10 þ/377X mice than in wild-type mice at P8 (Fig. 8A and B) .
There was no compensatory upregulation of Sox8 or Sox9 in the spinal cord of Sox10 þ/377X mice ( Fig. 8C and D) .
Time points chosen for the following analysis of oligodendrocyte development and homeostasis were identical to those for Schwann cells in the PNS. Again, Sox10 þ/lacZ mice were included. At P3, the number of cells marked by Olig2 and Sox10 and thus belonging to the oligodendroglial lineage were comparable among all three genotypes (Fig. 8E -J, T and U). In contrast, differences were detected for Plp1 and Myrf as markers of cells that have started differentiation and initiated myelin gene expression ( Fig. 8K -P, V and W). Their number was decreased in the spinal cord of Sox10 þ/377X and Sox10 þ/lacZ mice relative to the wild-type ( Fig. 8V and W) . However, there was no differences between Sox10 þ/377X and Sox10 þ/lacZ mice. The number of Pdgfrapositive OPCs was comparable among all three genotypes (Fig. 8Q-S and X ). There were also no changes in the number of Ki67-positive proliferating or cleaved caspase 3-positive cells undergoing apoptosis ( Fig. 8Y and Z) . As postnatal spinal cord development proceeds, more and more oligodendroglial cells differentiate and produce myelin, whereas the fraction of OPCs decreases until a steady state is achieved at P60. The total number of oligodendroglial cells in Sox10 þ/377X and Sox10 þ/lacZ mice remained comparable to the wild-type throughout postnatal spinal cord development ( Fig. 9A and B) . OPC numbers also exhibited no major alterations among genotypes (Fig. 9E) . The minor differentiation defect that we observed in Sox10 þ/377X and Sox10 þ/lacZ mice at P3
( Fig. 8V and W) was no longer visible at any of the later stages ( Fig. 9C and D) arguing that oligodendroglial differentiation is only transiently delayed in the heterozygous mice. There were also no alterations in Gfap or Iba1 immunoreactivity as indicators of astrogliosis or microgliosis in the spinal cord of heterozygous mice at any of the analyzed time points (data not shown).
In line with immunohistochemical findings, ultrastructural analysis of myelination in the spinal cord revealed no major abnormalities in the number and size distribution of axons, the structure and compaction of myelin or the g ratio (Fig. 10A-D) . We thus conclude that myelination is largely normal in the spinal cord of Sox10 þ/377X mice except for a mild transient delay in the first postnatal days. This delay is comparable to the one observed in Sox10 þ/lacZ mice.
We completed our study by characterizing oligodendroglial cells in the brain. We focused on the forebrain region and analyzed their number and their state of differentiation in cortex and corpus callosum at P7, P21 and P60. We did not detect any significant differences in the number of Olig2-positive oligodendroglial cells among the three genotypes at any of the analyzed time points (Fig. 11A and B) . For Sox10, a slight reduction was observed only at P7 in the corpus callosum of Sox10 þ/lacZ mice ( Fig. 11C and D) . Again, this is likely due to a detection problem resulting from reduced Sox10 amounts per cell in this genotype. Differentiating and myelin producing oligodendrocytes were present in slightly lower numbers at P7 in both Sox10 þ/377X and Sox10 þ/lacZ mice as evident from Myrf and Plp1 expression ( Fig. 11E-H) . The effect was on the verge of being statistically significant. However, reductions were transient and no longer observed at P21 or P60. The number of Pdgfra-positive OPCs were similar in the three genotypes at all analyzed time points ( Fig. 11I and J) . We conclude from these studies that the consequences of heterozygous Sox10 mutation or loss are comparable for the oligodendroglial population in forebrain and spinal cord. No evidence was obtained for a dominant function of the Sox10 Q377X mutation in brain or spinal cord of Sox10 þ/377X mice.
Discussion
In this study, we have generated mice that carry a Sox10 377X allele. In humans, this allele caused PCWH-like neurological symptoms in the two heterozygously affected siblings in whom it was identified (4). Considering the exclusive expression of Sox10 in myelinating glia of PNS and CNS and the phenotype in Sox10-deficient mouse mutants (9, 12, 21) , symptoms should be caused by cell-intrinsic abnormalities in myelinating glia. Using Sox10 þ/377X mice, we addressed the question whether the neurological phenotype of patients is reproduced in mice and can be detected as abnormalities in Schwann cells, oligodendrocytes or their myelin. Sox10 þ/lacZ mice do not exhibit abnormalities in peripheral or central glia. They present with a combination of pigmentation and enteric nervous system defects that are comparable to combined Waardenburg-Hirschsprung disease (WS4) in human patients and typical for the haploinsufficient situation (3, 4, 9) . Detection of glial defects in Sox10 þ/377X mice would have supported the assumption that the mutant Sox10 protein exerts dominant effects, and by extrapolation that the combination of neurological symptoms with Waardenburg-Hirschsprung disease in PCWH is a result of the presence of such dominant SOX10 proteins in patients. Somewhat to our surprise, we failed to detect any evidence for such dominant function in PNS or CNS. Despite clear evidence for the presence of substantial amounts of the mutant Sox10 protein and wild-type expression levels of the Sox10 377X allele, no major abnormalities were observed in Sox10
mice regarding development and maintenance of Schwann cells and oligodendrocytes or regarding generation and homeostasis of myelin. We only detected a slight and transient delay in oligodendroglial differentiation during the first postnatal days. However, this was similarly observed in Sox10 þ/lacZ mice as The results are surprising because we would have expected that the presence of a mutant Sox10 that has retained its DNAbinding ability but lost its major transactivation domain (23) , should at least interfere with the function of the wild-type Sox10 protein. The simplest explanation for the lack of such a dominant-negative function may be a dramatically lower expression of the mutant Sox10 relative to the wild-type version. However, our immunohistochemical and rtPCR data argue against that. We favor a different explanation. For one, the Sox10 Q377X mutant has retained a second internal and weaker transactivation domain, the so called K2 domain (17) . This K2 domain is required for Schwann cell differentiation and also has a minor impact on oligodendroglial differentiation and myelin gene expression in vivo (17) . It may thus be responsible for partial retention of transactivation capacity in the Sox10 Q377X mutant. Such residual activity may also explain why myelin expression in the perinatal spinal cord of Sox10 Q377X/Q377X embryos is not as severely reduced as in Sox10 lacZ/lacZ embryos. It also has to be taken into consideration that Sox10 performs many of its functions as homodimer and possibly as heterodimer with the related Sox9 and Sox8 (24, 25) . Previous work had also shown that a functional dimerization domain is essential for Sox10 function in Schwann cell differentiation and peripheral myelination in vivo (17) . The Sox10 Q377X mutant is still capable of dimerization. Heterodimers between wild-type and mutant Sox10 still contain a transactivation domain and such a dimer may still be fully or partially active. As surprising as they may be, our results are consistent with previously published data on this and other Sox10 truncation mutants. For one, the Sox10 Q377X mutant has previously been tested for its impact on neural crest development in chicken following in ovo electroporation (26) . Despite the very high levels usually reached during electroporation for the ectopically expressed protein, these studies failed to reveal any evidence of a dominant action for the Sox10 Q377X variant. Instead, it rather behaved like an inactive protein.
Additionally, there have also been reports that the Sox10 frameshift mutation in Dom mice, that has been instrumental in the original identification of Sox10 as a WS4-associated gene (10, 11) , leads to the production of a mutant Sox10 protein in vivo. In this mutant, the first 193 amino acids are followed by 99 additional amino acids that are not normally found in Sox10 (27) . Although it may have reduced DNA-binding activity, it is generally capable of DNA-binding (26, 27) . Still, Sox10 þ/dom mice do not differ phenotypically from Sox10 þ/lacZ mice provided they are kept on an identical genetic background. Thus, there is precedence that a Sox10 mutation that leads to a truncated protein in vivo does not function in a dominant fashion in mice. Our study thus comes to conclusions that are different from Ito et al. (15) who analyzed the phenotypic consequences of expression of a SOX10 c.1400del12 transgene that produces a mutant Sox10 with extended open reading frame. It has to be kept in mind that this mutation is very different from the truncated Sox10 Q377X analyzed in our study, and may thus behave differently. Additionally, it also needs to be emphasized that the experimental setup is different in the two studies. Whereas the Sox10 Q377X allele in our study replaces a wild-type allele, the SOX10 c.1400del12 transgene was expressed on the background of two wild-type alleles.
Many studies provide evidence that Sox10 function is strongly dose-dependent. As a result even overexpression of wild-type Sox10 may cause phenotypic abnormalities, and the study by Ito et al. (15) cannot distinguish between consequences of overexpression of the mutant Sox10 and Sox10 overexpression per se.
Considering that we do not find abnormalities in glial cells and myelin of PNS and CNS in heterozygous mice, it seems unlikely that there is a strict correlation between nonsense-/ frameshift mutations in the last exon, escape from NMD of the mutant transcript, expression of a dominant SOX10 and a PCWH-like phenotype. Our results would rather argue that the phenotypic manifestation of a particular SOX10 mutation is multifactorial and that the genetic background and modifiers are not only involved in the decision between Waardenburg, Hirschsprung and Waardenburg-Hirschsprung disease (7) but are also an essential factor in the manifestation of PCWH.
In this respect, it needs to be emphasized that our studies were conducted in mice on a mixed, largely C3H background. As modifiers are known to have a substantial impact on the phenotypic manifestation of Sox10 mutations in mice (4, 28, 29) , we cannot exclude that neurological symptoms would become tion in the wild-type arbitrarily set to 1. Statistically significant differences between heterozygous mutant genotypes and the wild-type were determined by two-tailed Student's t-test (*P 0.05; **P 0.01; ***P 0.001). in the wild-type arbitrarily set to 1. Statistically significant differences between heterozygous mutant genotypes and the wild-type were determined by two-tailed Student's t-test (*P 0.05; ***P 0.001).
apparent on a different genetic background in Sox10 þ/377X mice.
Even if this is the case, this would only strengthen our conclusion of a multifactorial cause for the exact disease phenotype resulting from SOX10 mutations.
Materials and Methods
Construction of targeting vectors, gene targeting, generation and genotyping of mouse mutants
Sequences corresponding to a neomycin resistance cassette with flanking loxP sites and the open reading frame for the mutant Sox10 Q377X protein were placed between 5 0 and 3 0 Sox10 genomic regions as homology arms (4.3 and 1.5 kb, respectively) in the context of a pPNT vector backbone as described (9, 17) . The targeting vector thereby replaced the Sox10-coding exons 3-5 by a continuous Sox10 reading frame with Q377X mutation (Fig. 1A) . The simultaneous insertion of a floxed neomycin cassette in intron 2 prevents transcription of all downstream sequences including the Sox10 Q377X open reading frame so that the initially generated Sox10 Sfl allele is a null allele.
The construct was linearized with PacI and electroporated into E14.1 ES cells followed by selection with G418 (400 mg per ml) and gancyclovir (2 mM). Selected ES cell clones were screened by southern blotting with a 0.6 kb 3 0 probe, which recognized a 4.9 kb fragment in case of the wild-type allele and a 2.6 kb fragment in case of the mutant allele in genomic DNA digested with BamHI and EcoRV (Fig. 1B) . Appropriate integration of the 5 0 end of the targeting construct was verified using a 0.6 kb 5 0 probe on ES cell DNA digested with SacI. This probe hybridized to a 10.7 kb fragment in the mutant allele as opposed to a 7.9 kb fragment in the wild-type allele (Fig. 1B) . Four ES cell clones were obtained that exhibited a correctly recombined allele. Two of these targeted ES cells clones were injected into C57Bl/6J blastocysts to generate chimeras. Germline transmission was achieved in chimeras from one ES cell clone. In the resulting heterozygous mice, the neomycin resistance cassette was removed by EIIa::Cre-mediated recombination (30) . This converts the Sox10 Sfl null allele into the Sox10 377X allele from which the Sox10 Q377X mutant is expressed (Fig. 1A) . Sequencing of genomic DNA from the altered Sox10 locus confirmed that no additional unintended mutations were introduced during cloning. The generation of mutant mice and their analysis were approved by the responsible local committees and government bodies. Genotyping of the original Sox10 Sfl and the final Sox10 (Fig. 1C) . For the Sox10 377X allele, two primers (5 0 -TCAGTCTCGGCTGTCCAGCC-3 0 and 5 0 -CCTGATCCC AACCGTCTCTA-3, primers 4 and 5 in Fig. 1A ) were used with location in intron 2 upstream and downstream the loxP site that remains after Cre-mediated recombination. A 525 bp fragment was indicative of the wild-type allele, a 628 bp fragment of the Sox10 377X allele (Fig. 1D ).
Mice were kept under standard housing conditions with 12:12 h light-dark cycles and continuous access to food and water in accordance with animal welfare laws. They were kept as heterozygotes and backcrossed on a C3H background. Both males and females of generations F2-F5 were used for the study. Sox9. Transcript levels were normalized to Rpl8.
Immunohistochemistry and in situ hybridization
Mice were collected as embryos on embryonic day (E) 12.5 and E18.5, as pups on postnatal day (P) 3 and P7, as adolescents at P21 and as young adult at P60. For analysis, tissue was fixed in 4% paraformaldehyde, transferred to 30% sucrose and frozen in Tissue Freezing Medium (Leica). Ten micrometre cryotome sections of spinal cord (at forelimb level), forebrain (level of hippocampal formation) or sciatic nerve (proximal part) were used for immunohistochemistry (18, 31) . The following primary antibodies were applied: guinea pig anti-Sox10 antiserum (1:1000 dilution) (19) , guinea pig anti-Sox8 antiserum (1:1000 dilution) (32), rabbit anti-Olig2 antiserum (1:1000 dilution, Millipore), rabbit anti-Oct6 antiserum (1:1000 dilution) (33) , rabbit anti-Iba 1 antiserum (1:250 dilution, Wako), rabbit anti-Sox9 antibodies (1:2000 dilution) (31), rabbit anti-Pdgfra antiserum (1:300 dilution, Samples were documented with a Leica DMI 6000B inverted microscope (Leica) equipped with a DFC 360FX camera (Leica). For in situ hybridization, 10 mm cryotome sections from spinal cord were incubated with DIG-labeled antisense riboprobes specific for Pdgfra, Mbp and Plp1 as described (12, 34) . Samples were analyzed and documented with a Leica MZFLIII stereomicroscope equipped with an Axiocam (Zeiss).
Electron microscopy
Spinal cord and sciatic nerve from P60 mice was processed for transmission electron microscopy as described (18) . Briefly, dissected tissues underwent fixation in cacodylate-buffered fixative containing 2.5% paraformaldehyde and 2.5% glutaraldehyde, followed by postfixation in cacodylate-buffered 1% osmium ferrocyanide, dehydration and embedding in Epon resin. Ultrathin sections (50 nm thickness) were stained with uranyl acetate and lead citrate and examined with a Zeiss Libra electron microscope (Carl Zeiss, Inc.). From electron microscopic picture, axon diameters and g ratios were determined as described (18) .
Protein extracts and western blotting
Whole-cell protein extracts were prepared from spinal cord tissue of embryos at E18.5 as described (21) . Protein extracts from wildtype and homozygous mutant littermates were size-fractionated on polyacrylamide-SDS gels, blotted onto nitrocellulose membranes and analyzed by western blotting using antisera against Sox10 (1:1000 dilution) and Gapdh (1:3000 dilution, Santa Cruz Biotechnology), protein A coupled to horseradish peroxidase (BioRad) and Luminol reagent for chemiluminescent detection.
Quantification and statistical analysis
For quantification of cell numbers, areas and g ratios, at least three spinal cord, brain or nerve sections from independent embryos or mice of each genotype were counted. All statistical analysis was performed with Prism6 software (GraphPad) or Excel 2016 (Microsoft Office). Statistically significant differences were determined by Student's t test.
